Shares of NMC Health PLC (LON:NMC) have received an average rating of “Buy” from the six research firms that are covering the firm, MarketBeat reports. Three investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The average 12-month price objective among brokers that have covered the stock in the last year is GBX 3,377 ($47.35).
Several equities analysts have recently commented on the stock. Berenberg Bank reaffirmed a “buy” rating and set a GBX 4,000 ($56.09) price objective on shares of NMC Health in a research note on Monday, January 29th. JPMorgan Chase & Co. downgraded shares of NMC Health to a “neutral” rating and increased their price target for the stock from GBX 2,730 ($38.28) to GBX 3,270 ($45.85) in a research note on Wednesday, January 24th. Barclays assumed coverage on shares of NMC Health in a research note on Friday. They issued an “overweight” rating and a GBX 4,100 ($57.49) price target for the company. Finally, Jefferies Group reissued a “hold” rating and issued a GBX 3,085 ($43.26) price target on shares of NMC Health in a research note on Wednesday, January 17th.
In related news, insider Mark Tompkins purchased 27,000 shares of the firm’s stock in a transaction that occurred on Friday, December 8th. The stock was bought at an average cost of GBX 2,914 ($40.86) per share, with a total value of £786,780 ($1,103,168.82). Also, insider Jonathan Bomford purchased 1,000 shares of the firm’s stock in a transaction that occurred on Monday, November 27th. The stock was bought at an average cost of GBX 2,877 ($40.34) per share, with a total value of £28,770 ($40,339.32). Over the last three months, insiders purchased 29,160 shares of company stock valued at $84,808,800.
Shares of NMC Health (LON NMC) traded down GBX 48 ($0.67) during trading hours on Friday, hitting GBX 3,208 ($44.98). 566,199 shares of the stock traded hands, compared to its average volume of 258,316. The company has a market capitalization of $6,560.00 and a P/E ratio of 5,728.57. NMC Health has a 52-week low of GBX 1,693 ($23.74) and a 52-week high of GBX 3,540 ($49.64).
WARNING: “Analysts Set NMC Health PLC (NMC) PT at $3,377.00” was reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this piece of content on another site, it was copied illegally and republished in violation of US & international trademark & copyright law. The correct version of this piece of content can be viewed at https://www.dispatchtribunal.com/2018/02/05/analysts-set-nmc-health-plc-nmc-pt-at-3377-00.html.
About NMC Health
NMC Health plc is a private healthcare services provider in the United Arab Emirates. The Company operates through two segments: healthcare and distribution & services. The healthcare segment is engaged in providing professional medical services, comprising diagnostic services, in and outpatient clinics, provision of all types of research and medical services in the field of gynecology, obstetrics and human reproduction and retailing of pharmaceutical goods.
Receive News & Ratings for NMC Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NMC Health and related companies with MarketBeat.com's FREE daily email newsletter.